Remdesivir Results Announced; FDA Alert for Obesity Tx Devices

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

2:59 AM (17 hours ago)

to me

If you are having trouble viewing this email, click here.

MUST READS Gilead, NIH Report Positive Results With Remdesivir for COVID-19 Adding High-Dose Chloroquine Not Advised for Severe COVID-19 FDA Approves Jublia for Onychomycosis in Pediatric Patients Update on Potential Risks Associated With Liquid-Filled Intragastric Balloons Mobocertinib Gets Breakthrough Status for NSCLC With EGFR Exon 20 Insertion Mutations FEATURE Patient’s Death Leads to Lawsuit After Physician Fails to Check Creatinine Level Before Infusing Drug COVID-19 Resource Center Featured Content Collection and Use of Real-World Data Continues to Grow Around the World CME/CE Spotlight Are Your Patients Using the Most Effective Contraceptive Methods for Them? AMA PRA Category 1 Credit(s)TM CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME